Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Tirzepatide for Sale > Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide
Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide buy - large image1
Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide buy - image1
Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide buy - image2
Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide buy - image3
Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide buy - image4
Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide buy - image5
Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide buy - image6

Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide

2046 Inquiries

Unit Price:

$61-69/MT FOB

Get Latest Price
CAS No.:

2023788-19-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

shenzhen

Brand:

lianyi

Packaging:

10mg/vial,10vials/box

Price valid (until):

2026-09-19

Company Type:
Distributor
Location:
China
Qualification:
Main Products:

GLP-1,Retatrutide,Selank,Tirzepatide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      ProdSales manager:Lily
    whatsapp:+85257230249
    Email:emma@lianyi-tech.cnuct Detail  


    Product introduction

    Tirzepatide  is a peptide-based medication that has garnered significant attention in the field of diabetes management. As a member of the glucagon-like peptide-1 (GLP-1) receptor agonist class, Tirzepatide offers a novel approach to addressing the complexities of type 2 diabetes mellitus (T2DM). This peptide-based therapy has demonstrated promising results in clinical trials, showcasing its potential to revolutionize diabetes treatment.

      The therapeutic potential of Tirzepatide extends beyond glycemic control, with emerging evidence suggesting its utility in addressing comorbidities commonly associated with T2DM. Preclinical studies have indicated potential benefits of Tirzepatide in preserving beta-cell function, reducing inflammation, and improving cardiovascular function, highlighting its broader impact on metabolic health. These findings underscore the transformative role of peptide-based therapies like Tirzepatide in reshaping the landscape of diabetes care.


    Effects and uses

    1.control the blood glucose level

    2.lose-weight

    3.Potential cardiovascular benefits

    Shop Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide-Detailed Image 1


    Peptide Storage Guidelines:

    General Tips When storing peptides, remember to:

    • Store peptide in a cold, dry, dark place

    • Avoid repeated freezing and thawing of peptide

    • Avoid overexposure to the air

    • Avoid light exposure

    • Avoid storing peptides in solution long term

    • Aliquot peptide according to experimental requirements



    Shop Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide-Detailed Image 2 Shop Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide-Detailed Image 3 Shop Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide-Detailed Image 4 Shop Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide-Detailed Image 5

    Shop Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide-Detailed Image 6 Shop Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide-Detailed Image 7

    Our Advantages

    Hebei Lianyi Technology Co., Ltd. offers high-quality bioactive peptides manufactured in our 5,000sqm factory. We provide Tirzepatide-peptide with exceptional quality and competitive pricing. Our products have received outstanding feedback from customers worldwide, ensuring reliability and satisfaction. Benefit from our advanced production processes and dedicated R&D team.


    Shop Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide-Detailed Image 8

    Company Profile

    Hebei Lianyi Technology Co., Ltd. is a leading manufacturer and global supplier of high-quality pharmaceutical and chemical peptide products. We specialize in the research, development, and production of a diverse range of peptide-based compounds that meet the rigorous demands of the international pharmaceutical and biotech industries.

    Our core commitment is to excellence and reliability. All our manufacturing processes are strictly conducted in facilities that comply with international Good Manufacturing Practice (GMP) standards. This ensures the utmost quality, purity, and consistency in every product we deliver, providing our clients with complete confidence for their critical applications.

    With a strong focus on the global market, we have successfully established a widespread distribution network. Our products are extensively exported to over 20 countries worldwide, serving key regions including Europe, the Americas, Southeast Asia, the Middle East, and Africa.

    Driven by innovation and a customer-centric approach, Hebei Lianyi Technology Co., Ltd. is dedicated to being your trusted partner for premium peptide solutions, supporting advancements in healthcare and technology across the globe.

    Shop Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide-Detailed Image 9


    Shop Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide-Detailed Image 10


    Shop Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide-Detailed Image 11

    Packing$Delivery


    Shop Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide-Detailed Image 12

    Shop Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide-Detailed Image 13 Shop Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide-Detailed Image 14 Shop Weight LossTirzepatide LY3298176 CAS 2023788-19-2 Vial 10mg 20mg Reta Peptide-Detailed Image 15 Shop Weight Loss Peptide Tirzepatide,Retatrutide, Cagrilintide, High Quality Lyophilized Powder-Detailed Image 16

    FAQ

    Q: What is Tirzepatide-peptide used for?

    A: Tirzepatide-peptide is primarily used for lean muscle development and weight loss.

    Q: What purity level does your Tirzepatide-peptide have?

    A: Our Tirzepatide-peptide boasts a 99% purity level.

    Q: Where are your products sold?

    A: Our products are sold in the United States, the United Kingdom, Russia, the Middle East, and Southeast Asia.

    Q: Do you offer OEM services?

    A: Yes, we provide OEM services for new product development.

    Q: What industries do you serve?

    A: We serve industries such as food and beverage, pharmaceuticals, and healthcare.

    Q: How can I be sure of the quality of your peptides?

    A: We have a dedicated R&D team and advanced production processes to ensure high-quality peptides.

    Q: What is the export percentage of your products?

    A: Over 99% of our products are exported worldwide.

    Q:What is your payment terms?

    A:We can accept payment terms by PayPal, Bitcoin, usdt, Bank Transfer

    Q:Delivery time?

    A:1-3 days after we receive your payment.

    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Categories:

    Other Chemical Drugs

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Distributor

    Main Products:

    GLP-1,Retatrutide,Selank,Tirzepatide

    Location:

    Room 704#-A010, Building 11, Block 16, Liangzhu Street, Yuhang District, Hangzhou City, Zhejiang Province

    Average lead Time:

    1

    Total Annual Revenue:

    Less than $1 million

    Total Employees:

    11-50

    Year of Establishment:

    2025

  • Inquiry History
    2046 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    2023788-19-2 in unlabeled vials 10, 15 and 30 mg

    10  Feb 14, 2024
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss 399 Inquiries

    10 MG Apr 3, 2024
    United States

    Tirzepatide Raw Powder Weight Loss Peptides CAS No 2023788-19-2 Tirzepatide Injection Peptides

    2 MT Dec 13, 2025
    Hongkong, China

    2023788-19-2

    1 KG Aug 13, 2026
    Germany

    2023788-19-2

    1 MG Jun 18, 2026
    United States

    2023788-19-2 Retatrutide

    1 G Sep 22, 2023
    United States

    Tirzepatide 2023788-19-2

    Feb 19, 2024
    United States

    Tirzepatide 2023788-19-2

    10 G Oct 31, 2023
    United States

    2023788-19-2 Trizepatide

    10 MT Oct 29, 2023
    United States

    Trizepatide 2023788-19-2 Raw Material LY3298176 Tirzepatide powder

    Dec 2, 2025
    United States

    Fat Burning Peptides Tirzepatide 10mg/Vial 15mg/Vial Tirzepatide CAS: 2023788-19-2

    1 MT Jan 25, 2024
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    1 MT Oct 20, 2023
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss

    2 KG Oct 20, 2023
    United States

    supply Tirzepatide Safe Material Shipping Trizepatide 2023788-19-2 Raw Tirzepatide powder

    10 MG Apr 4, 2024
    United States

    COA Offer Top quality Weight Loss Peptides Tirzepatide 10mg/vial GLP-1 2023788-19-2

    1 MT Sep 10, 2023
    Kenya

    Janoshik Test Tirzepatide 99% White powder High Quality Tirzepatide Weight loss CAS 2023788-19-2

    30 MG Dec 26, 2025
    United States

    Ex-factory price tirzepatide T30 10vials 30mg kit cas 2023788-19-2 for weight loss peptide

    10  Dec 30, 2024
    United Kingdom

    Manufacturer supply high quality hot sale lowest price Tirzepatide CAS NO,2023788-19-2 99% powder 2023788-19-2 Claire

    100 G Nov 4, 2023
    Canada

    99.9% Purity GLP-1 Injection Weight Loss Peptides Liraglutide Retatrutide Tirzepatide Semaglutide 5mg 10mg CAS 2023788-19-2

    2 MT Oct 22, 2023
    United Kingdom

    tirzepatide

    10 MG Oct 21, 2025
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.